PortfoliosLab logo
XOMA Corporation (XOMA)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US98419J2069

CUSIP

98419J206

IPO Date

Apr 5, 1989

Highlights

Market Cap

$286.39M

EPS (TTM)

-$1.65

PEG Ratio

-0.42

Total Revenue (TTM)

$20.63M

Gross Profit (TTM)

$20.62M

EBITDA (TTM)

-$22.74M

Year Range

$18.35 - $35.00

Target Price

$64.67

Short %

1.83%

Short Ratio

5.74

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
XOMA vs. SHELL.AS XOMA vs. XLE
Popular comparisons:

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in XOMA Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%500.00%1,000.00%1,500.00%2,000.00%December2025FebruaryMarchAprilMay
-99.50%
1,810.58%
XOMA (XOMA Corporation)
Benchmark (^GSPC)

Returns By Period

XOMA Corporation (XOMA) returned -7.95% year-to-date (YTD) and 2.11% over the past 12 months. Over the past 10 years, XOMA returned -10.46% annually, underperforming the S&P 500 benchmark at 10.45%.


XOMA

YTD

-7.95%

1M

19.81%

6M

-21.89%

1Y

2.11%

5Y*

0.65%

10Y*

-10.46%

^GSPC (Benchmark)

YTD

-3.77%

1M

3.72%

6M

-5.60%

1Y

8.55%

5Y*

14.11%

10Y*

10.45%

*Annualized

Monthly Returns

The table below presents the monthly returns of XOMA, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20251.26%-14.69%-12.20%20.62%0.62%-7.95%
20247.95%21.73%-1.07%5.36%1.78%-8.14%12.96%9.30%-9.47%14.05%10.76%-21.43%42.05%
202310.27%4.88%-0.80%-12.88%-7.56%11.12%-16.62%-10.98%0.50%33.78%-21.27%24.66%0.54%
2022-0.62%5.84%27.59%-31.27%-5.30%22.35%5.48%-15.40%-9.91%-7.54%27.84%-13.08%-11.75%
2021-17.92%-0.06%12.73%-6.74%-22.57%15.37%-4.71%-3.95%-20.47%1.01%-17.96%1.66%-52.75%
2020-15.05%4.79%-16.26%20.29%-15.77%-4.17%-15.49%13.89%-0.95%31.69%33.45%33.28%61.65%
2019-4.58%16.49%-11.95%-4.20%57.84%-20.62%22.88%-3.67%12.05%-2.13%26.91%11.52%115.81%
2018-7.58%-18.42%-24.63%17.75%-9.95%-2.66%17.19%-23.46%-6.19%-29.94%22.10%-15.83%-64.47%
20171.66%9.56%51.28%-2.25%-6.91%8.04%3.15%53.81%77.19%23.61%24.33%17.88%743.60%
2016-24.06%-24.75%1.71%5.90%-16.31%-19.53%21.71%-15.42%-19.12%-41.50%3.91%-24.37%-84.14%
2015-0.84%3.65%-1.36%-17.58%17.33%10.23%-81.17%13.73%-9.53%62.30%9.02%0.00%-62.95%
201415.45%7.59%-37.68%-14.78%-6.76%10.87%-15.47%12.89%-3.88%1.90%32.63%-36.91%-46.66%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of XOMA is 49, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of XOMA is 4949
Overall Rank
The Sharpe Ratio Rank of XOMA is 5353
Sharpe Ratio Rank
The Sortino Ratio Rank of XOMA is 4848
Sortino Ratio Rank
The Omega Ratio Rank of XOMA is 4545
Omega Ratio Rank
The Calmar Ratio Rank of XOMA is 5050
Calmar Ratio Rank
The Martin Ratio Rank of XOMA is 5050
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for XOMA Corporation (XOMA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

XOMA Corporation Sharpe ratios as of May 10, 2025 (values are recalculated daily):

  • 1-Year: 0.04
  • 5-Year: 0.01
  • 10-Year: -0.14
  • All Time: -0.16

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of XOMA Corporation compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time. For deeper analysis or to customize the calculation, use the Sharpe ratio tool.


Rolling 12-month Sharpe Ratio0.001.002.003.00December2025FebruaryMarchAprilMay
0.04
0.44
XOMA (XOMA Corporation)
Benchmark (^GSPC)

Dividends

Dividend History


XOMA Corporation doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2025FebruaryMarchAprilMay
-99.76%
-7.88%
XOMA (XOMA Corporation)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the XOMA Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the XOMA Corporation was 99.96%, occurring on Feb 10, 2017. The portfolio has not yet recovered.

The current XOMA Corporation drawdown is 99.76%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.96%Mar 7, 19916534Feb 10, 2017
-40.38%Jan 5, 1990182Sep 24, 1990100Feb 14, 1991282
-17.2%Sep 13, 198913Sep 29, 198964Jan 2, 199077
-12.82%Jun 19, 19899Jun 29, 198934Aug 17, 198943
-9.68%Feb 26, 19911Feb 26, 19914Mar 4, 19915

Volatility

Volatility Chart

The current XOMA Corporation volatility is 12.51%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%December2025FebruaryMarchAprilMay
12.51%
6.82%
XOMA (XOMA Corporation)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of XOMA Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of XOMA Corporation, comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 80.2% positive surprise.


-2.00-1.000.001.002.00AprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober
-0.06
-0.30
Actual
Estimate

Valuation

The Valuation section provides an overview of how XOMA Corporation is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for XOMA compared to other companies in the Biotechnology industry. XOMA currently has a PEG ratio of -0.4. This PEG ratio is negative, which typically signals that the company's earnings are expected to decline. A negative PEG is not considered meaningful for valuation purposes.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for XOMA relative to other companies in the Biotechnology industry. Currently, XOMA has a P/S ratio of 10.1. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for XOMA in comparison with other companies in the Biotechnology industry. Currently, XOMA has a P/B value of 3.6. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items